openPR Logo
Press release

Glycomics Market 2022 Clinical Research and Analysis- Thermo Fisher Scientific (US), New England Biolabs (US), Merck KGaA (Germany), Promega Corporation (US), Waters Corporation (US), Takara Bio Inc, (Japan)

11-15-2022 08:40 AM CET | Health & Medicine

Press release from: MarketsandMakets

Glycomics/ Glycobiology Market worth $3.7 billion by 2027

Glycomics/ Glycobiology Market worth $3.7 billion by 2027

Glycomics Market research report forecast 2022-2027 has been prepared by experienced and knowledgeable market analysts and researchers. Each section of the research study is specially prepared to explore key aspects of the industry. Buyers of the report will have access to accurate Porter's 5 Analysis, PESTLE, SWOT, and other types of analysis on the global Glycobiology market. The report aims to provide a thorough and accurate analysis of the industry, taking into account forecast, competitive intelligence, technical risks, innovations, and other pertinent data. Readers will learn about significant opportunities in the worldwide market, as well as major factors driving and inhibiting growth.

To Understand Business Strategies, Request For a Sample PDF Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525&utm_source=OPenpr&utm_medium=referral

The glycomics/glycobiology market is expected to grow at a CAGR of 15.5% during the forecast period. The growth of the market is due to emerging use of glycans as biomarker, increased prevalence of cancer, advancing technology for glycan analysis, collaborations and partnerships among market players for the development of glycobiology products.

The Prominent players covered in the Glycomics Market are:
Key players in the glycomics/glycobiology market are Thermo Fisher Scientific (US), New England Biolabs (US), Merck KGaA (Germany), Promega Corporation (US), Waters Corporation (US), Takara Bio Inc, (Japan), Bio-Techne (US), Agilent Technologies (US), Sumitomo Bakelite Co. Ltd. (Japan), Bruker Corporation (US), Shimadzu Corporation (Japan), Danaher Corporation (US), AMS Bio (UK), Ludger Ltd (UK), Z Biotech, LLC (US), Chemily Glycoscience (US), CD BioGlyco (US), GlycoDiag (France), Kode Biotech Limited (New Zealand), Glyxera GmBH (Germany), Lectenz Bio (US), Glycomix Ltd (UK), IEC Group (Italy), Asparia Glycomics (Spain) and Ray Biotech Life Inc. (US).

Drivers: Emergence of glycans as biomarkers

Glycans play a vital role in biology; alterations in glycans can lead to dangerous consequences, such as congenital disorders, heart diseases, growth defects, and epilepsy. Research has shown that mutation in glycosyltransferases or related enzymes modifies/alters the glycome and can cause over 100 types of human congenital disorders of glycosylation.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525&utm_source=OPenpr&utm_medium=referral

Recent Developments
• In April 2022, Bruker Corporation (US) acquired the IonSense (US) for expansion of the use of DART Mass spectrometers.
• In April 2021, GlycoNet (Canada) and BridgeBio Pharma Inc, (US) entered into partnership for developing medicines for treating genetic diseases through glycobiology research.

North America is the fastest-growing region of the glycomics/glycobiology market in 2022.
North America is estimated to be the fastest-growing segment of the market. The growth of the glycomics/glycobiology market in this region is driven by the presence of prominent market players offering glycomics products, increasing focus on glycomics research and its application in drug development and availability of research infrastructure in the US.

Avail 10% Discount on various license types on Immediate Purchase @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132685525&utm_source=OPenpr&utm_medium=referral

Table of Contents:
Glycomics Market Scenario 2022

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Glycomics market.

Chapter 2: Exclusive Summary - the basic information of the Glycomics Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Glycomics.

Chapter 4: Presenting the Glycomics Market Factor Analysis, Supply/Value Chain, PESTEL analysis, Market Entry, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region/Country 2022 - 2027

Chapter 6: Evaluating the leading manufacturers of the Glycomics market which consists of its Competitive Landscape, Peer Group Analysis, Market positioning & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2022-2027)

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

This Glycomics Market Research/Analysis Report Contains Answers to your following Questions:
1. Who are the key players in the glycomics/glycobiology market?

2. Which product segment dominates the glycomics/glycobiology market?

3. Which application segment dominates the glycomics/glycobiology market?

4. Which end user segment dominates the glycomics/glycobiology market?

5. What is the market size for the glycomics/glycobiology market?

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company's specific needs. The following customization options are available for this report:

An additional five company profiles

Get Special Pricing on Bundle Reports:
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=132685525&utm_source=OPenpr&utm_medium=referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glycomics Market 2022 Clinical Research and Analysis- Thermo Fisher Scientific (US), New England Biolabs (US), Merck KGaA (Germany), Promega Corporation (US), Waters Corporation (US), Takara Bio Inc, (Japan) here

News-ID: 2806524 • Views:

More Releases from MarketsandMakets

Warehouse Robotics Market Set to Grow at the Fastest Rate- Time to Grow your Revenue
Warehouse Robotics Market Set to Grow at the Fastest Rate- Time to Grow your Rev …
The warehouse robotics market is estimated to be worth USD 6.1 billion in 2023 and is projected to reach USD 10.5 billion by 2028, at a CAGR of 11.4% during the forecast period. The expansion of e-commerce industry driving significant revenue growth and rapid developments in robotics and artificial intelligence are major factors driving the global growth of the warehouse robotics market. Moreover, transformation of warehouses through the integration of
Global Vascular Patches Market Growth to Reach USD 517 million by 2027
Global Vascular Patches Market Growth to Reach USD 517 million by 2027
The global Vascular Patches Market is valued at an estimated USD 353 million in 2022 and is projected to reach USD 517 million by 2027, at a CAGR of 7.9% during the forecast period. Market growth is driven by the growing geriatric population and subsequent prevalence of vascular diseases and availability of reimbursement for vascular procedures, coupled with the growing adoption of biological patches. Key Market Players: LeMaitre Vascular, Inc. (US),
Mice Model Market Size, Share, Growth Rate, Demands, Trends, Key Players and Forecasts to 2029
Mice Model Market Size, Share, Growth Rate, Demands, Trends, Key Players and For …
The global Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying
Global Antibody Drug Conjugates Market Key Players are Daiichi Sankyo Company, Limited (Japan), Seagen Inc. (US), Gilead Sciences, Inc. (US) and Others
Global Antibody Drug Conjugates Market Key Players are Daiichi Sankyo Company, L …
The global Antibody Drug Conjugates Market in terms of revenue was estimated to be worth $9.7 billion in 2023 and is poised to reach $19.8 billion by 2028, growing at a CAGR of 15.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and

All 5 Releases


More Releases for Glycomics

Glycomics or Glycobiology Market Analysis with Research Report 2021
“The Glycomics/Glycobiology Market Research Report” examines the existing as well as sequential performance of the worldwide market. The report also calculates the forthcoming status of Glycomics/Glycobiology market based on thorough analysis. By providing exploratory techniques such as, qualitative and quantitative analysis the report presents a comprehensive analysis of market progression. The report provides Graphical presentation of information through charts, (graphs, diagrams as well as pictures) and easy understanding of the
Glycomics / Glycobiology Market | Growth With Recent Trends & Demand
According to a new report published by Allied Market Research, titled, “Glycomics / Glycobiology Market by Product [Enzymes (Glycosidases, Glycosyltransferases, Neuraminidases, Sialyltransferases, and Others), Instruments (Antibody Arrays, HPLC, Lectin Arrays, MALDI-TOF, Mass Spectrometers, and Other Glycomics Instruments), Kits (Glycan Labeling Kits, Glycan Purification Kits, Glycan Release Kits, and Others), Reagents (Glycoproteins, Monosaccharides, Oligosaccharides, and Others)], Application [Diagnostics, Drug Discovery & Development, Oncology, Immunology, and Others], and End User [Academic Research
Glycomics Market: Technological Innovations & Market Insights till 2030
The study of Glycomics Market published by Prophecy Market Insights offerings all compilation of the historical, current and future outlook of the market. This report is very helpful for understanding the market complexity. This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue etc. Also this
Global Glycomics/ Glycobiology Market 2018 - Danaher, ProZyme, Bruker, Promega
Apex Market Reports, recently published a detailed market research study focused on the “Glycomics/ Glycobiology Market” across the global, regional and country level. The report provides 360° analysis of “Glycomics/ Glycobiology Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Glycomics/ Glycobiology on
Glycomics Market worth 1211.4 Million USD by 2021
The global glycomics/glycobiology market is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3% during the forecast period. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of this market. The global glycomics/glycobiology market is broadly segmented into product, application, end
Global Glycomics/ Glycobiology Market Size, Status and Forecast 2022
This report studies the global Glycomics/ Glycobiology market, analyzes and researches the Glycomics/ Glycobiology development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Agilent Technologies Bruker Corporation Danaher Corporation Merck KGaA New England Biolabs ProZyme, Inc. R&D Systems, Inc. Shimadzu Corporation Takara Bio, Inc. Thermo Fisher Scientific Waters Corporation Sample of this report is available upon request @ https://www.qyresearchreports.com/sample/sample.php?rep_id=1336457&type=E Table of Contents Global Glycomics/ Glycobiology Market Size, Status